The expression of miR-203 has been reported to be significantly down-regulated in esophageal cancer. We showed here that overexpression of miR-203 in esophageal cancer cells dramatically increased cell apoptosis and inhibited cell proliferation, migration and invasion as well as tumor growth and down-regulated miR-21 expression. We subsequently identified that small GTPase Ran was a target gene of miR-203. Furthermore, Ran restoration partially counteracted the tumor suppressive effects of miR-203 and increased miR-21 expression. Taken together, our findings suggest that miR-203 may act as novel tumor suppressor in esophageal cancer through down-regulating the expression of Ran and miR-21.
Introduction
Esophageal cancer is sixth leading cause of cancer death worldwide with a variable geographic distribution. Two main histological types have been identified, esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), regarding to different etiologic and pathologic characteristics. EAC is common in western countries while ESCC is frequent in east Asia, especially in China whose incidence in the high-risk northern and central China exceeds 100 cases per 100,000 people per year [1] . Despite improvements in the diagnosis and treatment of this cancer, the overall survival for advanced and metastatic esophageal cancer is still poor, with a 5-year survival rate of less than 20% after surgery in China [1] .
Thus, there is a great need to disclose molecular mechanisms of pathogenesis of esophageal cancer to identify more tumor specific biomarkers and therapeutic targets for early diagnosis and treatment. The pathogenesis of esophageal cancer still remains unclear so far. It has been shown that both genetic and epigenetic alterations may be involved in the progress of this cancer. Genetic abnormalities such as gene amplification and mutation, chromosomal loss and gain or loss of heterozygosity (LOH) are important etiological factor involved in tumorigenesis of esophageal cancer [2] . Recently, epigenetic disruption such as aberrant CpG island methylation has been demonstrated as a key event in the development of esophageal cancer via regulating the expression of tumorrelated genes and microRNAs (miRNAs) [3] .
MiRNAs are an endogenous class of 20-25 nucleotide-long single-stranded non-coding RNAs that regulate gene expression at the posttranscriptional level by binding to the 3 0 -untranslated region (3 0 -UTR) of mRNA which subsequently leads to mRNA degradation and translation repression. Previous studies have demonstrated that a single miRNA may target multiple genes due to the imperfect complementarity with target mRNA, while the expression of a single gene may be modulated by different miRNAs [4] . The remarkable performance of individual miRNAs to modulate multiple transcripts allows miRNAs to control a variety of physiological processes such as cell proliferation, differentiation and apoptosis. Thus, alterations in miRNA expression are thought to play critical roles in cancer initiation and progression through regulating the expression of various oncogenes and tumor suppressive genes [5] .
Over the past few years, aberrant miRNA expression profiles were reported in esophageal cancer tissues compared with matched non-malignant tissues [3, 6] . MiR-21 was observed to be frequently up-regulated in ESCC cell lines and tumor tissues [7] .
Up-regulation of several miRNAs such as miR-93, miR-106b, miR-373, miR-192, miR-196a and miR-147, was also detected in ESCC [8] [9] [10] [11] [12] [13] . Among them, the overexpression of miR-129 has been observed to be associated with poorer post-operative survival [14] . Several other miRNAs were reported to be down-regulated in ESCC such as miR-203, miR-375, miR-125b, miR-100, miR-133a, miR133b, miR-143 and miR-145 [12, [15] [16] [17] , suggesting they may exert tumor suppressive functions. It has been reported that miR-133a, miR-133b and miR-145 suppressed tumor cell growth and invasion through targeting FSCN1 gene [15] .
MiR-203 locates at chromosome 14q32-33 and has been identified as a skin-specific keratinocyte-derived miRNA involved in keratinocyte differentiation [18] . Previous report showed that overexpression of miR-203 inhibited the proliferation of esophageal cancer cells through targeting DNp63 [19] . However, further studies are needed to provide novel insights into molecular mechanisms underlying the regulatory activities of miR-203 in esophageal cancer. In our present studies, regulatory functions of miR-203 on the proliferation, apoptosis, migration and invasion of esophageal cancer cells as well as on tumor growth in vivo and its molecular mechanisms were characterized.
Materials and methods

Plasmid constructs
Hsa-miR-203 (miR-203) precursor was purchased from Songon Tech (Beijing, China) and inserted into pcDNA6.2-GW/EmGFP-miR vector (named pcDNA/miR-203) according to the manufacturer's instructions (Invitrogen, USA). Scramble miR-NA was cloned into the same vector and used as negative control (named pcDNA/ miR-NC). The sequence of control miRNA is 5 0 -AGGTACGAAACGCTAAGAAT-3 0 . To construct luciferase reporter vector, the human small GTPase Ran 3 0 -UTR containing putative binding sites for miR-203 was amplified by PCR and cloned in pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega, USA) into restriction sites Sac-1 and Sal-1. The construct was named pmiR-GLO-Ran. The primers used were as follows: 5 0 -CTAAGCGGAACATGTGCTTCATCT-3 0 (Forward primer for Ran 3 0 UTR), 5 0 -GATATTTGAAATACAACTTTATTC-3 0 (Reverse primer for Ran 3 0 UTR). As a control, pmiR-GLO-Ran-Mut vector was constructed by site-directed mutagenesis using pmiR-GLO-Ran plasmid as template. For the mutated construct, three nucleotides TCA in miR-203 seed match site were substituted with CGC. The primers used were as follow: 5 0 -TATAGGCAGCTGTCCTGTGATGTC-3 0 (Forward primer for Ran 3 0 UTR-Mut), 5 0 -GGCGAATACAACTTTATTCTGATT-3 0 (Reverse primer for Ran 3 0 -UTR-Mut). The accuracy of all cloning was confirmed by sequencing.
Cell transfection
Human esophageal squamous cancer cell line (Ec-109) was kindly provided by Dr. Ling Zhou from Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (CDC). Cells were cultured and maintained in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 lg/ml streptomycin in a humidified incubator with 5% CO 2 at 37°C. All culture materials were purchased from GIBCO, USA. Cell transfection was performed using Lipofectamine 2000 (Invitrogen, USA). Briefly, cells at approximately 60% confluence in 6-well plates were transfected with miR-203 expressing vector (pcDNA/ miR-203) or control vector (pcDNA/miR-NC). Stable miR-203 overexpressing clones and control transfected-cells were selected by using blasticidin at a concentration of 4 lg/ml. Individual clones were isolated after 3 weeks of selection and the expression of miR-203 was confirmed by real-time PCR.
Small GTPase Ran-directed small interfering RNA (siRNA) oligonucleotide was purchased from Inovogen Tech (Beijing, China). The sequence is:siRNA-425-Ran: 5 0 -GCAACAAAGUGGAUAUUAA-3 0 . Scramble siRNA was used as negative control (siRNA-NC). The sequence is 5 0 -UUCUCCGAACGUGUCACGUTT-3 0 . SiRNA oligonucleotide duplexes were synthesized and 1 lg of siRNA mimic was transfected into cells by using Lipofectamine 2000
(Invitrogen, USA) according to the manufacturer's guidelines.
Clinical samples
Twelve pairs of primary esophageal squamous cell carcinoma tissues and corresponding adjacent normal esophageal tissues were obtained from patients in Jieyang City People's Hospital with informed consent and agreement. All tissue samples were collected from untreated patients undergoing surgery and were immediately frozen in liquid nitrogen and stored at À80°C until for the extraction of total RNA.
Quantitative real-time PCR (qRT-PCR)
Real-time PCR was used to detect the expression of mature miR-203, miR-21 and the expression of primary transcript of small GTPase Ran. Total RNA was extracted from cultured cells or frozen tissues using Trizol reagent (Invitrogen, USA) following the protocols of the manufacturer. For miRNA expression analysis, 1 lg of total RNA was applied for reverse transcription to synthesize miRNA cDNA using NCode™ VILO™ miRNA cDNA synthesis kit (Invitrogen, USA À44Ct method for relative quantification of gene expression was used to determine miRNAs and Ran mRNA expression levels. Real-time PCR primers were designed using Primer Express software (version 5.0, Applied Biosystems).
Cell proliferation, cell cycle and apoptosis analysis
5.0 Â 10 4 cells were inoculated in 25 cm 2 flasks with 5 ml fresh media in triplicate. Viable cells were counted by trypan blue exclusion method with a hemacytometer every 24 h. Every sample was counted three times, and an average cell density was calculated. For cell cycle analysis, cultured cells were harvested, washed twice by PBS, and fixed in 70% ethanol at 4°C overnight. Cells were incubated with propidium iodide at room temperature for 1 h and were analyzed by flow cytometry (Beckman, USA). For apoptosis analysis, miR-203 and control-transfected cells were processed by using PE annexin V apoptosis detection kit (BD, USA) in compliance with the manufacturer's protocol and subjected to flow cytometric analysis (Beckman, USA).
Transwell migration and invasion assays
The migration and invasion assays were carried out using Transwell insert chambers (Corning, USA). For migration assay, 1 Â 10 5 cells were plated into the upper chamber in serum-free medium in triplicate. Medium containing 20% FBS in the lower chamber served as chemoattractant. After incubation for 24 h at 37°C in a 5% CO 2 humidified incubator, cells in the upper chambers were removed by wiping with a cotton swab and cells migrated to the lower surface of filter were fixed in 70% ethanol for 30 min and stained with 0.2% crystal violet for 10 min. Cell migration was scored by counting five random fields per filter under a light microscope. For invasion assay, 3 Â 10 5 cells were seeded into upper chambers precoated with matrigel (BD, USA) in serum-free medium in triplicate. Medium with 20% FBS were added to the lower chamber to serve as chemoattractant. After incubation for 24 h at 37°C, non-invading cells on the upper surface of filter were removed with cotton swabs and invading cells that migrated to the lower surface of filter were fixed, stained and scored as described above.
Lentivirus production and transduction
Lentiviral particles expressing wild-type human small GTPase Ran were produced with ViraPower Lentiviral Packaging Kit (Invitrogen, USA). The coding region of human small GTPase Ran was amplified by PCR and subcloned into EcoRI and XhoI sites of pLenti6. 
Soft-agar colony assay
Anchorage-independent cell growth was assayed in 6-well plates. 1 Â 10 4 cells were seeded in 2 ml of standard growth medium containing 0.3% low-melting-temperature soft-agar (Lonza, USA) and plated onto solidified 0.7% soft-agar base layer dissolved in complete culture medium in 6-well plates. Cultures were fed once a week with 0.5 ml of complete medium. Triplicate samples were prepared for each transfectant and the experiment was repeated twice. Colonies becoming visible microscopically after 4 weeks were photographed with an Olympus phase-contrast microscope.
In vivo tumorigenesis assay
Female athymic BALB/C nude mice (4-6 weeks) were purchased from Laboratory Animal Center of the Army Research Center (Beijing, China). All animals were housed at pathogen-free condition. Animal experiments were performed in accordance with current guidelines for the Care and Use of Laboratory Animals of Army Research Center. All experimental procedures were conducted with the guidelines provided by NIH (National Cancer Institute, USA. Website: http://ncifrederick.cancer.gov/Lasp/Acuc/Frederick/GuidelinesFnl.aspx). For xenografts, nude mice were divided into 4 groups (n = 8 for each) and were subcutaneously (s. 
Western blotting analysis
Cultured cells were harvested and lysed with RIPA lysis buffer (Beyotime, China) for 10 min on ice. After centrifugation at 12,000g for 10 min, the concentration of proteins was measured using Bradford's reagent (Bio-Rad laboratories, USA). The protein samples were denatured by boiling for 10 min and loaded onto SDS-PAGE (12%) gel for electrophoresis. The proteins were transferred onto PVDF membrane (Millipore, USA) which was then incubated in the blocking solution (5% non-fat dried milk) at room temperature for 1 h. The anti-Ran antibody (Novus, USA) was added into blocking solution and incubated at 4°C overnight. The membranes were subsequently incubated with the secondary goat anti-mouse antibody conjugated with fluorescent dyes: IRDye 800 CW (KPL, USA) for 45 min. Protein expression was normalized against GAPDH expression (RD, USA). Blotting images were acquired with the Odyssey infrared imaging system (Li-COR Biosciences, USA) and analyzed by the software provided by the manufacturer.
Dual-luciferase reporter assay
For luciferase reporter assay, Ec-109 cells (2.5 Â 10 5 ) seeded in 6-well plates were cotransfected with 0.5 lg of miR-203 expressing plasmid and 0.5 lg of pmiR-GLO-Ran or pmir-GLO-Ran-Mut plasmids using Lipofectamine 2000. Empty vector was used as negative control (pmiR-GLO-NC). At 24 h post-transfection, luciferase activity was analyzed using the Dual-Glo Ò Luciferase Assay System (Promega, USA). Luciferase activity was presented as an average of three independent experiments performed in triplicate.
Statistical analysis
Data are expressed as mean ± SD from at least three separate experiments. The differences between groups were analyzed using Student's t-test. The difference was deemed statistically significant at p < 0.05.
Results
Overexpression of miR-203 induces cell apoptosis, suppresses cell proliferation, migration and invasion and inhibits tumorigenicity
The expression of miR-203 has been reported to be significantly down-regulated in ESCC [3] . However, the involvement of miR-203 in the pathogenesis of esophageal cancer is still far from being fully elucidated. In current studies, to investigate the potential impacts of miR-203 on the proliferation, apoptosis, migration, invasion and tumorigenicity of esophageal cancer cells, miR-203 precursor and scramble miRNA was cloned and exogenously expressed in esophageal cancer cells. Stably transfected cells were selected by blasticidin. The ectopic expression of mature miR-203 in stable transfectants was confirmed by qRT-PCR (Supplementary Fig. 1) .
In order to investigate the impact of miR-203 on cell proliferation and cell cycle progress, trypan blue exclusion assay was carried out to measure cell growth and cell cycle analysis was conducted with flow cytometry. The data showed that overexpression of miR-203 suppressed the proliferation of Ec-109 cells (Supplementary Fig. 2A ), modulated cell cycle by inducing G1 arrest and decreased the percentages of Ec-109 cells in S phase compared to control (Supplementary Fig. 2B ). Our observations are consistent with previous report [19] . Supplementary Fig. 3 ).
Transwell migration and matrigel invasion assays were performed to assess the effects of miR-203 on cell migration and invasion. As shown in Fig. 1A and B, compared to the scramble control, exogenous expression of miR-203 could effectively repress the migration ability and invasion capacity of Ec-109 cells by about 32.4% (p < 0.01) and about 76.8% (p < 0.01), respectively, indicating suppressive effects of miR-203 on the migration and invasion of ESCCs.
We next examined the effects of miR-203 on the tumorigenicity of esophageal cancer cells. Anchorage-independent growth assay demonstrated that miR-203-transfected cells generated much fewer and smaller colonies in soft agar compared with control transfectants (Fig. 1C) . For tumor formation assay in nude mice, animals (n = 8) were initially inoculated s. 
Small GTPase Ran is a direct target gene of miR-203
In order to disclose the molecular mechanism through which miR-203 realizes its tumor-suppressive functions, computational prediction using open access websites including TargetScan (http://www.targetscan.org), PicTar (http://pictar.mdc-berlin.de) and MiRanda (http://www.microrna.org) and the target prediction methods previously reported [20, 21] were adopted to identify functionally relevant targets of miR-203. Small GTPase Ran was found to be the target gene of miR-203, which contains putative target sequence. Compared to control, the decreased expression of this protein in miR-203-transfected cells was confirmed by both Western-blot ( Fig. 2A) and real-time PCR (Fig. 2B) .
We further tested whether Ran protein is a direct target of miR-203 by luciferase assay. 3 0 -UTR region of Ran-encoding gene containing putative binding site of miR-203 and its site-directed substitution mutant (Fig. 2C) were cloned into luciferase reporter vector (named PmiR-GLO-Ran and PmiR-GLO-Ran-mut, respectively) and co-transfected with miR-203, respectively. Cells co-transfected with empty vector (PmiR-GLO-vector) and miR-203 were used as negative control (PmiR-GLO-NC). The relative luciferase activity was significantly down-regulated by about 43.5% in the reporter construct containing wild type 3 0 -UTR compared to the mutant and empty vector control (Fig. 2D) . These results suggest that small GTPase Ran is a direct downstream target gene of miR-203 and miR-203 suppresses the expression of Ran through directly binding to its 3 0 -UTR.
MiR-21 is down-regulated by miR-203 through targeting small GTPase Ran
MiR-21 has been identified as the most commonly overexpressed oncogenic miRNA in solid tumors including ESCC [22, 23] . In order to verify whether ectopic expression of miR-203 could influence the expression of miR-21, we compared the expression of miR-21 in miR-203-and vector control-transfected Ec-109 cells by real-time PCR. The results showed that the expression of miR-21 was significantly reduced in miR-203-transfected Ec-109 cells to about 45.8% of the control (p < 0.01) (Fig. 3A) , suggesting that miR-203 could be a potential negative regulator for miR21expression.
Small GTPase Ran was identified as a direct target gene of miR-203 in our current studies, we further examined whether miR-203 down-regulated miR-21 expression through repressing Ran. To verify this hypothesis, we designed Ran specific siRNAs to specifically suppress the expression of Ran in Ec-109 cells and the expression level of miR-21 in Ran specific siRNAs-transfected cells was compared with that in scramble siRNA-transfected cells which were used as negative control (siRNA-NC). After transfection of siRNAs into Ec-109 cells, compared to scramble control, significant suppression of Ran expression was found in Ran specific siRNA-transfected cells (siRNA-425-Ran) by both Western-blot (Fig. 3B ) and real-time PCR (p < 0.01) (Fig. 3C) analyses.
Following this confirmation, the expression level of miR-21 was analyzed by real-time PCR in siRNA-425-Ran-and scramble control siRNA-transfected cells. The results showed that the expressions of miR-21 was remarkably down-regulated in Ran specific siRNAtransfected Ec-109 cells compared to control-transfected cells (p < 0.01) (Fig. 3D) . These data suggest that the decreased expression of miR-21 correlates with the specific Ran silencing by siRNA suppression and miR-203 may down-regulate miR-21 expression through repressing Ran. However, the analysis also showed that the expression of Ran and miR-21 was lower in tumors induced by miR-203-transfected cells than in those induced by scramble control miRNA-transfected cells (Supplementary Fig. 5 ). Data obtained suggest that miR-203 may be one of the critical events that modulate the expression of oncogenic protein small GTPase Ran and oncomir miR-21 in esophageal cancer.
Restoration of Ran counteracts the tumor suppressive effects of miR-203
We identified here that miR-203 exerted tumor suppressive effects in ESCCs and small GTPase Ran was its direct target gene. To investigate whether the regulatory effects of miR-203 on the apoptosis, proliferation, migration, invasion and tumor formation of Ec-109 cells are mediated by Ran, we cloned ORF of wild-type human Ran without its 3 0 -UTR into lentiviral expression vector to avoid miRNA interfering. Ran was exogenously expressed in miR-203-transfected Ec-109 cells by lentivirus infection (named miR-203 + pLCM-Ran). Empty lentiviral vector was introduced in miR-203-transfected Ec-109 cells (named miR-203 + pLCM) and miR-NC cells (named miR-NC + pLCM) which were used as negative Fig. 6 ). Our analysis further found that Ran restoration not only increased the proliferation (Supplementary Fig. 7 ) and the apoptosis resistance ( Supplementary Fig. 8 ) of miR-203-trasnfected cells but also partially increased their capacity of migration (Fig. 4A) and invasion (Fig. 4B ) when compared with negative control, indicating that the suppressive effects of miR-203 on cell migration and invasion could be partially rescued by Ran restoration.
We showed above that miR-21 expression could be down-regulated by miR-203, we thereafter examined the effect of Ran restoration in miR-203-transfected cells on the expression of miR-21. Our results showed that restoring expression of Ran increased miR-21 expression by about 2 folds (p < 0.01) (Fig. 4C) , indicating that Ran restoration counteracts the inhibitory effects of miR-203 on miR-21 expression.
MiR-21 expression was up-regulated by Ran restoration, we therefore investigated its implication in anti-tumor effects of miR-203 using xenograft experiments. 
MiR-203 expression inversely correlates with the expression of Ran and miR-21 in ESCC
The expression of miR-203, Ran and miR-21 was quantitatively analyzed by real-time PCR in 12 pairs of primary ESCC and corresponding adjacent normal esophageal tissues. Results showed that the overall average expression level of miR-203 was lower in tumor tissues than in adjacent normal tissues. In contrast, the overall average expression levels of Ran and miR-21 were higher in tumor tissues relative to normal tissues (Fig. 5) , indicating that miR-203 expression has an inverse correlation with the expression of Ran and miR-21 in ESCC when compared to adjacent normal tissues, which is consistent with our above-mentioned data that ectopic expression of miR-203 down-regulates miR-21 expression through targeting Ran.
Discussion
Deregulation of oncogene and tumor-suppressor gene expression has been identified as one of the critical causes of tumorigenesis. The recent discovery of miRNAs provides additional new insights into the molecular mechanism of gene expression control. It has been reported that miRNA could regulate gene expression by inducing target mRNA cleavage or translational repression through binding to its 3 0 -UTR. Aberrant miRNA expression was recently found in cancer and recognized as a hallmark of cancer [4, 5] . Studies on miRNA expression profiling and their functions in cancer have indeed provided evidence of the implication of miRNA with tumor development and progression [4, 5] . However, up to date, only a small proportion of identified miRNAs have been investigated to elucidate their precise biological roles in esophageal cancer. Down-regulation of miR-203 has been reported in a number of different types of cancers including ESCC [24] [25] [26] . The aim of current work is to elucidate the biological functions of miR-203 in [19, 27] and inhibits the migration of prostate cancer cells by targeting Lasp1, Ckap2, Wasf1 and Asap1 [28] . In our present reports, studies on molecular mechanism of miR-203 in tumor suppression revealed that small GTPase Ran is a direct target gene of miR-203 validated by its remarkable down-regulation in miR-203-expressed cancer cells and by luciferase assay. It is consistent with a recent report that Ran up-regulation is correlated with miR-203 down-regulation during the repair of damaged skin [29] . Ran is a small GTPase of the Ras superfamily and involved in regulation of multiple important biological processes, especially in nucleocytoplasmic transport, mitotic spindle assembly and nuclear envelope formation. The overexpression of Ran has been observed in diverse tumor types and its up-regulation is correlated with a poor prognosis of tumor patients, suggesting the importance of this small GTPase in tumor growth and progression [30] [31] [32] . To specifically address the implication of Ran in the tumor suppressive roles of miR-203, wild-type Ran was exogenously expressed in miR-203-transfected esophageal cancer cells. Our observations showed that the restoration of Ran partially increased apoptotic resistance and rescued the suppressive effects of miR-203 on cell proliferation, migration and invasion. However, our xenograft experiments showed that Ran restoration could partially enhance xenograft growth of miR-203-transfected cells in vivo, suggesting that down-regulation of Ran partially contributed to the tumor suppressive effects of miR-203.
Significant down-regulation of miR-21 was observed in miR-203-transfected ESCCs. MiR-21 is the only miRNA known to be frequently overexpressed in many types of human malignancy and actually considered as oncogenic miRNA that acts as oncogene [22] . Extensive studies showed that its overexpression is involved in all the known carcinogenic processes such as hyperproliferation, angiogenesis, invasion and metastasis and significantly associated with the poor prognosis of tumor patients [22, 23] . In the present studies, overexpression of miR-203 led to the down-regulation of miR-21 expression. We further identified that Ran was able to regulate miR-21 expression, and miR-203 could down-regulate miR-21 expression through repressing Ran. In our experiments, Ran knockdown by Ran-specific siRNA reduced the expression of miR-21 and Ran restoration in miR-203-transfected cells increased miR-21 expression and therefore counteracted inhibitory effects of miR-203 on miR-21 expression. It should be mentioned that it may be a particular phenomenon observed in Ec-109 cells and be different in other cell lines, considering that the pattern of expression of miRNAs is tissue dependent. Furthermore, an inverse correlation of miR-203 expression with the expression of Ran and miR-21 was observed in ESCC tissues when compared to corresponding adjacent normal tissues, suggesting that misregulation of miR-203 may be a critical event responsible for the overexpression Ran and miR-21 in ESCC. This observation is consistent with our data that miR-203 down-regulates miR-21 expression through suppressing Ran. However, how Ran regulates miR-21 expression remains to be elucidated.
In conclusion, the data presented here suggest that miR-203 plays tumor suppressor roles in esophageal cancer cells and small GTPase Ran is a direct downstream target of miR-203 which can be involved in multiple tumor suppressive effects of miR-203. We established for the first time a link between miR-203, small GTPase Ran and miR-21, which has been identified as an oncogenic miRNA ubiquitously overexpressed in diverse types of malignancy. The identification and characterization of the tumor suppressive effects of miR-203 may provide a novel therapeutic approach for ESCC treatment.
